Analysts at Japan Catalyst write in a research note that Taisho has already been pushing a globalisation strategy through deals such as its acquisitions of overseas OTC medicine companies like ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果一些您可能无法访问的结果已被隐去。
显示无法访问的结果